Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-050286
Filing Date
2008-03-07
Accepted
2008-03-07 16:51:23
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1251909
2 1998 EQUITY INCENTIVE PLAN, AS AMENDED & RESTATED dex101.htm EX-10.1 46309
3 1998 DIRECTOR STOCK OPTION PLAN, AS AMENDED & RESTATED dex102.htm EX-10.2 29978
4 1999 SUPPLEMENTAL EQUITY COMPENSATION PLAN, AS AMENDED & RESTATED dex103.htm EX-10.3 36933
5 2005 SUPPLEMENTAL EQUITY COMPENSATION PLAN, AS AMENDED AND RESTATED dex105.htm EX-10.5 37327
6 FORM OF RESTRICTED STOCK AGREEMENT dex1035.htm EX-10.35 41114
7 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 719
8 CONSENT OF KPMG LLP dex231.htm EX-23.1 3316
9 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 4205
10 CERTIFICATION OF CEO UNDER SECTION 302 dex311.htm EX-31.1 8792
11 CERTIFICATION OF CFO UNDER SECTION 302 dex312.htm EX-31.2 9038
12 CERTIFICATION OF CEO AND CFO UNDER SECTION 906 dex32.htm EX-32 4066
  Complete submission text file 0001193125-08-050286.txt   1475209
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Filer) CIK: 0001040017 (see all company filings)

EIN.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24241 | Film No.: 08674794
SIC: 2836 Biological Products, (No Diagnostic Substances)